Quest Diagnostics Stock (NYSE: DGX) stock price, news, charts, stock research, profile.
|Vol / Avg.57.486K / 909.242K||Mkt Cap15.354B|
|Day Range136.020 - 137.135||52 Wk Range119.590 - 158.336|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|2023-11-17||JP Morgan||John Stansel||Maintains||NeutralNeutral||Raises||148.00||149.00|
|2023-11-06||Piper Sandler||David Westenberg||Maintains||NeutralNeutral||Raises||130.00||140.00|
|2023-10-16||Piper Sandler||David Westenberg||Maintains||NeutralNeutral||Lowers||145.00||130.00|
|Ticker||Company||Chg %||Mkt Cap|
|HIMS||Hims & Hers Health||-0.51%||1.9B|
You can purchase shares of Quest Diagnostics (NYSE: DGX) through any online brokerage.
The latest price target for Quest Diagnostics (NYSE: DGX) was reported by JP Morgan on Friday, November 17, 2023. The analyst firm set a price target for 149.00 expecting DGX to rise to within 12 months (a possible 9.11% upside). 17 analyst firms have reported ratings in the last year.
The stock price for Quest Diagnostics (NYSE: DGX) is $136.56 last updated Today at December 4, 2023 at 3:13 PM UTC.
The next Quest Diagnostics (DGX) dividend date is projected to be Tuesday, January 16, 2024.
Quest Diagnostics’s Q4 earnings are confirmed for Thursday, February 1, 2024.
There is no upcoming split for Quest Diagnostics.
Quest Diagnostics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NYSE.